头部和部癌症:病原和向治疗
Yan Liu1,2, Nannan Zhang3, Yi Wen4
1Frontiers Medical Center Tianfu Jincheng Laboratory Chengdu China.
MedComm
|August 22, 2024
概括
头癌 (HNC) 是一种侵略性的癌症,常常是晚诊断的,抗治疗的. 本综述探讨了HNC病原和新型治疗策略,包括免疫疗法和向疗法,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 分子生物学分子生物学
背景情况:
- 头癌 (HNC) 是一种高度侵袭性的恶性瘤.
- 延迟诊断,复发,转移和耐药性存在重大挑战.
- 危险因素包括吸烟,酒精,HPV感染和遗传/表观遗传倾向.
研究的目的:
- 为了审查头癌的发病过程.
- 总结目前和新兴的HNC治疗策略.
- 讨论最近的进展和未来的研究方向.
主要方法:
- 关于临床前和临床研究的综合文献综述.
- 对HNC的遗传,表观遗传,信号通路和免疫调节机制的分析.
- 评估各种治疗方式及其临床试验结果.
主要成果:
- HNC的发病包括复杂的遗传/表观遗传变化和失调的信号传递.
- 标准治疗方法 (手术,放射治疗,化疗) 有局限性,特别是在转移性疾病中.
- 新兴疗法,如向疗法,免疫疗法,抗体-药物合物和mRNA疫苗显示出有前途.
结论:
- 了解HNC的发病性对于开发有效的治疗方法至关重要.
- 组合疗法和新的治疗方法为管理HNC提供了新的希望.
- 对新的标和治疗策略的持续研究对于改善生存率至关重要.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861


